You just read:

Foamix to Announce Topline Results in Phase 2 Clinical Trial of FMX-103 Minocycline Topical Foam for Moderate-to-Severe Papulopustular Rosacea

News provided by

Foamix Pharmaceuticals Ltd

09 Sep, 2016, 08:00 ET